Unbound MEDLINE

Implications of immunomodulatory interleukins for the hyperimmunoglobulinemia of Sjögren's syndrome. Cellular immunology [Cell Immunol] Journal article

 
TitleImplications of immunomodulatory interleukins for the hyperimmunoglobulinemia of Sjögren's syndrome.
Author(s)Girón-González JA, Baturone R, Soto MJ, Márquez M, Macías I, Montes de Oca M, Medina F, Chozas N, García-Pérez S 
InstitutionInternal Medicine Services, Hospital Universitario Puerta del Mar, Cádiz, Spain. joseantonio.giron@uca.es
SourceCell Immunol 2009; 259(1):56-60.
MeSHAdult
Aged
Antibodies, Antinuclear
Female
Humans
Hypergammaglobulinemia
Immunoglobulins
Interleukins
Male
Middle Aged
Prospective Studies
Protein Array Analysis
Sjogren's Syndrome
AbstractA prospective study of 37 patients with pSS and 20 healthy controls was performed to analyze the differences in circulating levels of macrophage-derived and Th1/Th2 cytokines which could explain the hyperimmunoglobulinemia, characteristic of primary Sjögren's syndrome (pSS). Serum levels of interleukin (IL)-6, IL-10, IL-12, gamma-interferon (gamma-INF) and IL-4 were analyzed by a sandwich immunoassay-based protein array system. When compared with the control group, higher levels of IL-6, IL-12 and IL-10 and a lower Th1/Th2 ratio, as demonstrated by the gamma-INF/IL-4 ratio, were detected in patients. The levels of IL-4 were notably higher in pSS patients with monoclonal gammopathy. Serum IL-4 and IL-10 levels and immunoglobulin G concentrations were significantly correlated. In conclusion, patients with pSS show a state of macrophage and T-lymphocyte activation with increased concentrations of cytokines implicated in the differentiation of B cells and secretion of immunoglobulins.
Languageeng
Pub Type(s)Journal Article
PubMed ID19540455
  
Advertise on this site.